article thumbnail

Pharma’s ESG goals need to underscore push for health equity

Pharmaceutical Technology

Over recent years, many pharmaceutical companies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. GlobalData is the parent company of Pharmaceutical Technology. Health disparities today. PhrMA’s health equity initiative.

article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

Still, in 2021, we have seen the industry evolve and develop strategies on how to establish a viable ECA. In the US healthcare system, drug makers seek reimbursement from payers by conducting database and post-marketing studies in which ECAs are often leveraged for price negotiations and coverage.

FDA 89
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top Performing Drug – Trikafta/Kaftrio (May Edition)

PharmaShots

In 2022, Vertex Pharma’s net product revenue spiked by 18%, vs. 2021, mainly due to influx of Trikafta in multiple countries internationally and the growing performance of Trikafta in the U.S. Limited Coverage: Insurance coverage and reimbursement policies may vary, leading to potential barriers for some patients in accessing Trikafta.

article thumbnail

Medical debt resources

The Checkup by Singlecare

Additionally, medical debt can impact anyone, regardless of background or the quality of health insurance coverage. The prevalence of medical debt in the United States Today, more people have health insurance coverage than ever before because of the passage of the Affordable Care Act.

article thumbnail

How much is Nexplanon without insurance?

The Checkup by Singlecare

The patent protection for Nexplanon typically prevents other pharmaceutical companies from creating a generic version until the patent expires. How much does Nexplanon cost without insurance? Without insurance coverage, individuals can expect varying costs. The patent for Nexplanon is expected to expire in the U.S.

article thumbnail

What HCPs think about health equity in cancer care

pharmaphorum

Pierce, MD, FASTRO, FASCO selected the theme for the 2021 Annual Meeting: ‘Equity: Every Patient. While a theme constantly raised by HCPs advocating for their patients, the focus heightened in HCP online conversations at this ASCO’s 2021 virtual congress. Over 40% of those posts cited insurance companies alongside these access issues.

Insurance 116